+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027

  • PDF Icon

    Report

  • 602 Pages
  • January 2023
  • Region: Global
  • Howe Sound Research
  • ID: 5472973

Whole Genome Sequencing Costs Plummet and So Do Prices. Industry on Verge of Breakout in Healthcare, Consumer and Agricultural Markets. A New Industry Emerges.

Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What’s holding the industry back? Where are the over 800 locations that have high throughput devices?

Our facts and support = Your success.

The plummeting costs for Whole Genome Sequencing are creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.  

Table of Contents

1 Market Guides 
1.1 Whole Genome Sequencing Market - Strategic Situation Analysis & COVID Impact
1.1.1 Selected Genetic Testing Companies Revenue & Growth 
1.1.2 Selected Companies Growth Chart
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition  
2.1 Whole Genome Sequencing Definition In This Report 
2.1.1 Whole and Exome Sequencing 
2.1.2 Research and Clinical 
2.1.3 Clinical Tumor
2.1.4 Clinical Pathogen
2.1.5 Agri/Other
2.1.6 Direct to Consumer 
2.2 The Genomics Revolution 
2.3 Market Definition 
2.3.1 Revenue Market Size  
2.4 Perspective: Healthcare, the IVD Industry
2.4.1 Global Healthcare Spending 
2.4.2 Spending on Diagnostics
2.4.3 Important Role of Insurance for Diagnostics 
2.5 Sizing the Genome - Not What You Think 
2.5.1 Cost, Price and Genome Size, Pricing Practice 
2.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts

3 Market Overview  
3.1 Market Participants Play Different Roles
3.1.1Instrument Manufacturer
3.1.2 Independent lab specialized/esoteric
3.1.3 Independent lab national/regional
3.1.4 Independent lab analytical 
3.1.5 Public National/regional lab
3.1.6 Hospital lab
3.1.7 Physician lab
3.1.8 DTC Lab
3.1.9 Sequencing Labs  
3.1.10 Audit body 
3.2 Whole Genome Sequencing - Markets, Examples and Discussion  
3.2.1 Direct to Consumer - Two Approaches
3.2.1.1 The New Age of Medical Information
3.2.1.2 Dangers in  DTC-WGS - Health Costs and Regulation
3.2.1.3 Newborn and Prenatal - A Brave New World 
3.2.1.4 DTC - How Many Segments?
3.2.2 Research Markets
3.2.2.1 Research Funding and Capital Expense 
3.2.2.2 WGS Datasets Preferred
3.2.2.3 Existing research repurposed
3.2.2.4 Organism Wide Market 
3.2.2.5 Service Suppliers Respond
3.2.3 Clinical - Understanding Germline and Somatic  
3.2.3.1 Somatic - Chasing Mutations and Pharmacogenomics  
3.2.4 Pathogen Testing  
3.2.4.1 The Hepatitis C Story
3.2.4.2 Will the Microbiology Department Disappear?
3.2.5 AgriBio - Big Business 
3.2.5.1 GMO is Here to Stay
3.2.5.2 WGS Benefits and Risks
3.2.5.3 The New Agriculture
3.3 Industry Structure  
3.3.1 Hospital’s Testing Share 
3.3.2 Economies of Scale  
3.3.3 Instrument Manufacturer Role
3.3.4 Healthcare Industry Impacts - Still Struggling
3.3.4.1 Can the Healthcare Industry Adapt?
3.3.4.2 Genetic Counselling as an Industry 
3.3.4.3 WGES Adoption and Cannibalization
3.3.4.4 The Meaning of Grail 

4 Market Trends
4.1 Factors Driving Growth 
4.1.1 Diagnostic Factors 
4.1.2 Interpreting the Code Otherwise 
4.1.3 Changes in Agriculture 
4.1.4 Fertility Technology Comes of Age
4.1.5 Pathogen Challenges  
4.2 Factors Limiting Growth
4.2.1 Increased Competition Lowers Price  
4.2.2 Lower Costs
4.2.3 Healthcare Cost Concerns Curtail Growth 
4.2.4 Wellness has a downside
4.2.5 GMO Opposition Movement  
4.3 Sequencing Instrumentation
4.3.1 Instrumentation Tenacity
4.3.2 Declining Cost Changes Industry Structure 
4.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS 
4.3.4 llumina  
4.3.5 ION
4.3.6 Pacific Biosystems
4.3.7 Roche 454
4.3.8 SOLiD
4.3.9 Oxford Nanopore
4.3.9.1 What is Oxford Nanopore Sequencing?
4.3.9.2 What can Oxford Nanopore Sequencing be used for?  
4.3.9.3 Oxford Nanopore Products
4.3.10 Long Reads - Further Segmentation
4.3.11 Linked Reads
4.3.12 Targeted Sequencing Adopts CRISPR 
4.3.13 New Sequencing Technologies  
4.3.13.1 RNAP sequencing
4.3.13.2 In vitro virus high-throughput sequencing  
4.3.13.3 Tunnelling currents DNA sequencing  
4.3.13.4 Sequencing by hybridization
4.3.13.5 Sequencing with mass spectrometry  
4.3.13.6 Microfluidic Sanger sequencing  
4.3.13.7 Microscopy-based techniques

5 WGES Recent Developments  
5.1 Recent Developments - Importance and How to Use This Section 
5.1.1 Importance of These Developments  
5.1.2 How to Use This Section 
5.2 Genomics England, Aims to Sequence 100K Newborns  
5.3 Juno Diagnostics NIPT With At-Home Sample Collection 
5.4 Cardio Diagnostics Launches Genetic Cardio Risk Test 
5.5 Universal Genetic Testing in Breast Cancer Further Supported 
5.6 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests 
5.7 MyOme Lands Investment for WGS 
5.8 GenomSys Gains CE Mark for New Genomic Analysis Software 
5.9 WGS Finds Lung Cancers Fall Into Molecular Subtypes 
5.10 Testing Distinguishes Benign Tumors From Precancerous Condition 
5.11 Plan to Sequence All Newborns in UK 
5.12 Clear Labs Raises $60M for Nanopore Sequencing  
5.13 Variantyx Expands Into Prenatal, Cancer Testing 
5.14 Whole-Genome Sequencing Aids Diagnosis in Stockholm  
5.15 Variantyx Raises $20M  
5.16 Nonacus WGS Service for SARS-CoV-2 Laboratories 
5.17 Center to Report Risk Scores in Clinical WGS 
5.18 Stanford Launches WGS for Cardiovascular Testing 
5.19 Illumina and NY Healthcare Partner on Clinical WGS 
5.20 Increased Adoption of WGS Needs Acceptance by Payors, Providers  
5.21 Veritas Intercontinental Completes €5M Series B Financing Round 
5.22 M2GEN and Discovery Life Sciences in Bioinformatics Agreement 
5.23 Genomics England Adopts Quantum ActiveScale Object Storage 
5.24 GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx 
5.25 NHS Wales Introduces WGS for Critically Ill Newborns 
5.26 Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test 
5.27 C2i Genomics to Launch Trials for MRD Detection Tech  
5.28 Roche Acquires Sequencing Company Stratos Genomics 
5.29 UK COVID-19 Sequencing Consortium Launches 
5.30 Invitae Acquires Three Companies: YouScript, Genelex, Diploid 
5.31 Experience From Centralized Genomic Medicine Lab 
5.32 MGI to Enable $100 Human Genome 
5.33 Nebula Genomics offers  $299 WGS 
5.34 Team to Study Campylobacter Omics  
5.35 Veritas Genetics Restarts US Business  
5.36 NEOGEN, Gencove partner to advance animal genomics 
5.37 UK Whole-Genome Sequencing Project Obtains £200M 
5.38 WGS may help with disease outbreaks  
5.39 Veritas Cuts WGS Price by 40% 
5.40 Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing 
5.41 Machine-learning system used to diagnose genetic diseases 
5.42 Whole Genome Sequencing for healthy creates controversy 
5.43 Nebula Genomics Offers FREE Whole Genome Sequencing 

6 Profiles of Key Companies 
6.1 10x Genomics, Inc
6.2 1928 Diagnostics 
6.3 23andME Inc
6.4 Abbott Laboratories
6.5 AccuraGen Inc
6.6 Adaptive Biotechnologies 
6.7 Admera Health, LLC
6.8 Agilent/Dako
6.9 Akonni Biosystems
6.10 Amoy Diagnostics Co., Ltd
6.11 Ancestry.com LLC
6.12 Anchor Dx
6.13 ARUP Laboratories
6.14 Baylor Miraca Genetics Laboratories
6.15 Beckman Coulter Diagnostics
6.16 Becton, Dickinson and Company  
6.17 BGI Genomics Co. Ltd
6.18 Bioarray Genetics
6.19 Biocept, Inc.  
6.20 Biodesix Inc.  
6.21 BioFluidica
6.22 BioGenex  
6.23 Biolidics Ltd
6.24 bioMérieux Diagnostics
6.25 Bioneer Corporation
6.26 Bio-Rad Laboratories, Inc
6.27 Bio-Techne
6.28 C2i Genomics 
6.29 Caris Molecular Diagnostics
6.30 CellMax Life  
6.31 Centogene 
6.32 Circulogene  
6.33 Clear Labs
6.34 Clinical Genomics
6.35 Complete Genomics, Inc. - A BGI Company 
6.36 Dante Labs
6.37 Datar Cancer Genetics Limited  
6.38 Day Zero Diagnostics.  
6.39 Diasorin S.p.A
6.40 Epic Sciences
6.41 Epigenomics AG
6.42 Eurofins Scientific  
6.43 Excellerate Bioscience
6.44 Fabric Genomics  
6.45 Freenome  
6.46 FUJIFILM Wako Diagnostics  
6.47 Fujirebio
6.48 Fulgent Genetics  
6.49 GE Global Research
6.50 Gencove 
6.51 Genedrive
6.52 GeneFirst Ltd
6.53 Genetron Holdings 
6.54 Genewiz
6.55 Genomics England  
6.56 Genomics Personalized Health (GPH)
6.57 GenomOncology
6.58 Genzyme Corporation
6.59 Grifols
6.60 Guardant Health  
6.61 Guardiome 
6.62 HeiScreen  
6.63 Helix 
6.64 Helomics
6.65 Hologic  
6.66 HTG Molecular Diagnostics
6.67 Human Longevity, Inc
6.68 iCellate  
6.69 Illumina  
6.70 Incell Dx
6.71 Inivata 
6.72 Invitae Corporation  
6.73 Invivoscribe 
6.74 Karius
6.75 Lunglife AI Inc 
6.76 Macrogen
6.77 MDNA Life SCIENCES, Inc
6.78 MDx Health 
6.79 Medgenome
6.80 Meridian Bioscience
6.81 Mesa Biotech (Thermo Fisher)
6.82 Mesa Laboratories, Inc
6.83 miR Scientific
6.84 MNG Labs
6.85 NantHealth, Inc
6.86 Natera 
6.87 Nebula Genomics
6.88 NeoGenomics  
6.89 New England Biolabs, Inc
6.90 Novogene Bioinformatics Technology Co., Ltd
6.91 Omega Bioservices  
6.92 Oncocyte 
6.93 OncoDNA
6.94 OpGen  
6.95 ORIG3N, Inc
6.96 Origene Technologies  
6.97 Oxford Nanopore Technologies
6.98 Panagene
6.99 Pathogenomix  
6.100 Perkin Elmer 
6.101 Personal Genome Diagnostics
6.102 Personalis
6.103 Precipio
6.104 PrecisionMed
6.105 Promega 
6.106 Protagen Diagnostics 
6.107 Qiagen  
6.108 QuantuMDx  
6.109 Regeneron Pharmaceuticals  
6.110 Roche Molecular Diagnostics
6.111 Roswell Biotechnologies  
6.112 Seegene
6.113 Sequencing.com  392  
6.114 Siemens Healthineers 
6.115 simfo GmbH  
6.116 Singlera Genomics Inc
6.117 SkylineDx 
6.118 Standard BioTools
6.119 Sure Genomics, Inc
6.120 Sysmex 
6.121 Sysmex Inostics 
6.122 Tempus Labs, Inc
6.123 Thermo Fisher Scientific Inc
6.124 Variantyx 
6.125 Volition  
6.126 Vyant Bio 

7 The Global Market for Whole Genome Sequencing 
7.1 Global Market Overview by Country
7.1.1 Table - Global Market by Country  
7.1.2 Chart - Global Market by Country  
7.2 Global Market by Application - Overview
7.2.1 Table - Global Market by Application
7.2.2 Chart - Global Market by Application - Base/Final Year Comparison
7.2.3 Chart - Global Market by Application - Base Year  
7.2.4 Chart - Global Market by Application - Final Year
7.2.5 Chart - Global Market by Application - Share by Year 
7.2.6 Chart - Global Market by Application - Segment Growth  
7.3 Global Market by Organism - Overview 
7.3.1 Table - Global Market by Organism
7.3.2 Chart - Global Market by Organism - Base/Final Year Comparison
7.3.3 Chart - Global Market by Organism - Base Year  
7.3.4 Chart - Global Market by Organism - Final Year  
7.3.5 Chart - Global Market by Organism - Share by Year
7.3.6 Chart - Global Market by Organism - Segment Growth  
7.4 Global Market by Product - Overview
7.4.1 Table - Global Market by Product  
7.4.2 Chart - Global Market by Product - Base/Final Year Comparison  
7.4.3 Chart - Global Market by Product - Base Year
7.4.4 Chart - Global Market by Product - Final Year
7.4.5 Chart - Global Market by Product - Share by Year  
7.4.6 Chart - Global Market by Product - Segment Growth

8 Global Whole Genome Sequencing Markets - by Application  
8.1 Research
8.1.1 Table Research - by Country  
8.1.2 Chart - Research Growth
8.2 Clinical Human
8.2.1 Table Clinical Human - by Country 
8.2.2 Chart - Clinical Human Growth
8.3 Clinical Tumor
8.3.1 Table Clinical Tumor - by Country  
8.3.2 Chart - Clinical Tumor Growth
8.4 Clinical Pathogen 
8.4.1 Table Clinical Pathogen - by Country 
8.4.2 Chart - Clinical Pathogen Growth  
8.5 Direct to Consumer  
8.5.1 Table Direct to Consumer - by Country
8.5.2 Chart - Direct to Consumer Growth
8.6 Agriculture/Other
8.6.1 Table Agriculture/Other - by Country 
8.6.2 Chart - Agriculture/Other Growth  

9 Global Whole Genome Sequencing Markets - by Organism  
9.1 Human  
9.1.1 Table Human - by Country  
9.1.2 Chart - Human Growth 
9.2 Pathogen  
9.2.1 Table Pathogen - by Country
9.2.2 Chart - Pathogen Growth 
9.3 Other Organism 
9.3.1 Table Other Organism - by Country
9.3.2 Chart - Other Organism Growth

10 Global Whole Genome Sequencing Markets - by Product 
10.1 Instruments 
10.1.1 Table Instruments - by Country
10.1.2 Chart - Instruments Growth  
10.2 Reagents
10.2.1 Table Reagents - by Country  
10.2.2 Chart - Reagent Growth  
10.3 Analysis  
10.3.1 Table Analysis - by Country
10.3.2 Chart - Analysis Growth
10.4 Software & Other  
10.4.1 Table Software & Other - by Country
10.4.2 Chart - Software & Other Growth

11 Vision of the Future of Whole Genome Sequencing
 
12 Appendices
12.1 United States Medicare System: Laboratory Fees Schedule  
12.2 The Most Used IVD Assays  
12.3 The Highest Grossing Assays  
12.4 The Whole Genome Sequence of SARS-CoV-2

Table of Tables
Table 1  The Base Pairs 
Table 2 Most Common Traditional Genetic Disorders
Table 3 List of GLOBAL SEQUENCING LOCATIONS  
Table 4  Market Players by Type 
Table 5 The Different Markets for Whole Genome Sequencing  
Table 6 DTC Sub Segments 
Table 7  Roles of WGS in AgriBio 
Table 8 The Factors Driving Growth
Table 9 Factors Limiting Growth 
Table 10 - Listing of Current NGS Instrument Specifications 
Table 11 Six New Sequencing Technologies 
Table 12 - Global Market by Region  
Table 13 Global Market by Application
Table 14 Global Market by Organism
Table 15 Global Market by Product 
Table 16 Research by Country 
Table 17  Clinical Human by Country
Table 18 Clinical Tumor by Country
Table 19 Clinical Pathogen by Country 
Table 20 Direct to Consumer by Country  
Table 21 Agriculture/Other by Country 
Table 22 Human by Country 
Table 23  Pathogen by Country 
Table 24 Other Organisms by Country
Table 25 Instruments by Country
Table 26  Reagents by Country  
Table 27 Analysis by Country  
Table 28 Software & Other by Country  
Table 29 Clinical Lab Fee Schedule 
Table 30  The Most Common Assays  
Table 31 Largest Revenue Assays 

Table of Figures
Figure 1 Global Healthcare Spending 
Figure 2 The Lab Test Pie 
Figure 3 Size of Genome for Various Species  
Figure 4 - Cost To Sequence a Human Genome  
Figure 5 Base Year Country Market Share Chart  
Figure 6 Global Market by Application - Base vs. Final Year
Figure 7 Global Market by Application Base Year
Figure 8 Global Market by Application Final Year
Figure 9 Application Type Share by Year
Figure 10 By Application Segment Growth 
Figure 11 By Organism - Base vs. Final Year  
Figure 12 By Organism Market Base Year  
Figure 13 By Organism Market Final Year  
Figure 14 By Organism Share by Year
Figure 15 By Organism Segment Growth  
Figure 16 By Product - Base vs. Final Year 
Figure 17 By Product Market Base Year 
Figure 18 By Product Market Final Year 
Figure 19 By Product Share by Year 
Figure 20 By Product Segment Growth 
Figure 21 Research Growth 
Figure 22 Clinical Human Growth 
Figure 23 Clinical Tumor Growth 
Figure 24 Clinical Pathogen Growth  
Figure 25 Direct to Consumer Growth 
Figure 26 Agriculture/Other Growth 
Figure 27 Human Growth
Figure 28 Pathogen Growth
Figure 29 Other Organism Growth 
Figure 30 Instruments Growth 
Figure 31 Reagent Growth  
Figure 32 Analysis Growth 
Figure 33 Software & Other Growth

Samples

Loading
LOADING...

Companies Mentioned

  • 10x Genomics, Inc
  • 1928 Diagnostics 
  • 23andME Inc
  • Abbott Laboratories
  • AccuraGen Inc
  • Adaptive Biotechnologies 
  • Admera Health, LLC
  • Agilent/Dako
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd
  • Ancestry.com LLC
  • Anchor Dx
  • ARUP Laboratories
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company  
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc.  
  • Biodesix Inc.  
  • BioFluidica
  • BioGenex  
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • C2i Genomics 
  • Caris Molecular Diagnostics
  • CellMax Life  
  • Centogene 
  • Circulogene  
  • Clear Labs
  • Clinical Genomics
  • Complete Genomics, Inc. - A BGI Company 
  • Dante Labs
  • Datar Cancer Genetics Limited  
  • Day Zero Diagnostics.  
  • Diasorin S.p.A
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific  
  • Excellerate Bioscience
  • Fabric Genomics  
  • Freenome  
  • FUJIFILM Wako Diagnostics  
  • Fujirebio
  • Fulgent Genetics  
  • GE Global Research
  • Gencove 
  • Genedrive
  • GeneFirst Ltd
  • Genetron Holdings 
  • Genewiz
  • Genomics England  
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health  
  • Guardiome 
  • HeiScreen  
  • Helix 
  • Helomics
  • Hologic  
  • HTG Molecular Diagnostics
  • Human Longevity, Inc
  • iCellate  
  • Illumina  
  • Incell Dx
  • Inivata 
  • Invitae Corporation  
  • Invivoscribe 
  • Karius
  • Lunglife AI Inc 
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health 
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • Mesa Laboratories, Inc
  • miR Scientific
  • MNG Labs
  • NantHealth, Inc
  • Natera 
  • Nebula Genomics
  • NeoGenomics  
  • New England Biolabs, Inc
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices  
  • Oncocyte 
  • OncoDNA
  • OpGen  
  • ORIG3N, Inc
  • Origene Technologies  
  • Oxford Nanopore Technologies
  • Panagene
  • Pathogenomix  
  • Perkin Elmer 
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega 
  • Protagen Diagnostics 
  • Qiagen  
  • QuantuMDx  
  • Regeneron Pharmaceuticals  
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies  
  • Seegene
  • Sequencing.com 
  • Siemens Healthineers 
  • simfo GmbH  
  • Singlera Genomics Inc
  • SkylineDx 
  • Standard BioTools
  • Sure Genomics, Inc
  • Sysmex 
  • Sysmex Inostics 
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc
  • Variantyx 
  • Volition  
  • Vyant Bio 

Methodology

Loading
LOADING...